The Tie1 and Tie2 receptor tyrosine kinases and the angiopoietin growth factor ligands, Ang1-4, are essential for vascular maturation. Targeted deletion of any of the Tie1,Tie2 or Ang1 genes in mice results in embryonic lethality during embryonic days 9.5–13.5. The receptors are expressed mainly in endothelial cells, while Ang1 is produced by perivascular cells and thought to stabilize quiescent endothelium. In contrast, Ang2 is secreted by endothelial cells in angiogenic vasculature, such as in tumors, leading to destabilization of the endothelium. Ang1 multimers stimulate the phosphorylation of Tie1 and Tie2, while Ang2 functions as a context-dependent agonist/antagonist for Tie2. Ang1 has promising vascular protective effects as an anti-permeability, anti-inflammatory and cell survival factor, but it can also induce vessel remodelling. The angiopoietin-Tie signalling pathway may be a therapeutically useful target in the treatment of a number of diseases, including oedema, endotoxaemia, transplant arteriosclerosis and cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Partanen, J. et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12, 1698–1707 (1992).
Dumont, D.J., Yamaguchi, T.P., Conlon, R.A., Rossant, J. & Breitman, M.L. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7, 1471–1480 (1992).
Dumont, D.J., Gradwohl, G.J., Fong, G.H., Auerbach, R. & Breitman, M.L. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 8, 1293–1301 (1993).
Iwama, A. et al. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 195, 301–309 (1993).
Manning, G., Whyte, D.B., Martinez, R., Hunter, T. & Sudarsanam, S. The protein kinase complement of the human genome. Science 298, 1912–1934 (2002).
Davis, S. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161–1169 (1996).
Maisonpierre, P.C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55–60 (1997).
Kim, I. et al. Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett 443, 353–356 (1999).
Valenzuela, D.M. et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96, 1904–1909 (1999).
Lee, H.J. et al. Biological characterization of angiopoietin-3 and angiopoietin-4. Faseb J 18, 1200–1208 (2004).
Dumont, D.J. et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8, 1897–1909 (1994).
Puri, M.C., Rossant, J., Alitalo, K., Bernstein, A. & Partanen, J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. Embo J 14, 5884–5891 (1995).
Sato, T.N. et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 367, 70–74 (1995).
Puri, M.C., Partanen, J., Rossant, J. & Bernstein, A. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 126, 4569–4580 (1999).
Suri, C. et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171–1180 (1996).
Holash, J. et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994–1998 (1999).
Yancopoulos, G.D. et al. Vascular-specific growth factors and blood vessel formation. Nature 407, 242–248 (2000).
Teichert-Kuliszewska, K. et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49, 659–670 (2001).
Gale, N.W. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3, 411–423 (2002).
Bogdanovic, E., Nguyen, V.P. & Dumont, D.J. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci 119, 3551–3560 (2006).
Daly, C. et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 103, 15491–15496 (2006).
Davis, S. et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10, 38–44 (2003).
Kim, K.T. et al. Oligomerization and multimerization is critical for angiopoietin-1 to bind and phosphorylate tie2. J Biol Chem 280, 20126–20131 (2005).
Saharinen, P. et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol 169, 239–243 (2005).
Brindle, N.P., Saharinen, P. & Alitalo, K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98, 1014–1023 (2006).
Eklund, L. & Olsen, B.R. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312, 630–641 (2006).
Cho, C.H. et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 101, 5547–5552 (2004).
Koblizek, T.I., Weiss, C., Yancopoulos, G.D., Deutsch, U. & Risau, W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8, 529–532 (1998).
Zhang, Z.G., Zhang, L., Croll, S.D. & Chopp, M. Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience 113, 683–687 (2002).
Cho, C.H. et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci USA 101, 5553–5558 (2004).
Kim, I. et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-Kinase/Akt signal transduction pathway. Circ Res 86, 24–29 (2000).
Jones, P.F. Not just angiogenesis–wider roles for the angiopoietins. J Pathol 201, 515–527 (2003).
Mandriota, S.J. et al. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am J Pathol 156, 2077–2089 (2000).
Fiedler, U. et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103, 4150–4156 (2004).
Fiedler, U. et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12, 235–239 (2006).
Huang, Y.Q., Li, J.J. & Karpatkin, S. Identification of a family of alternatively spliced mRNA species of angiopoietin-1. Blood 95, 1993–1999 (2000).
Kim, I. et al. Characterization and expression of a novel alternatively spliced human angiopoietin-2. J Biol Chem 275, 18550–18556 (2000).
Yamakawa, M. et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93, 664–673 (2003).
Xu, Y. & Yu, Q. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 276, 34990–34998 (2001).
Xu, Y., Liu, Y.J. & Yu, Q. Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans. J Biol Chem 279, 41179–41188 (2004).
Korhonen, J. et al. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80, 2548–2555 (1992).
Kaipainen, A. et al. Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res 54, 6571–6577 (1994).
Korhonen, J., Polvi, A., Partanen, J. & Alitalo, K. The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene 9, 395–403 (1994).
Dumont, D.J. et al. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203, 80–92 (1995).
Hashiyama, M. et al. Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells. Blood 87, 93–101 (1996).
Yano, M. et al. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood 89, 4317–4326 (1997).
Chen-Konak, L. et al. Transcriptional and post-translation regulation of the Tie1 receptor by fluid shear stress changes in vascular endothelial cells. Faseb J 17, 2121–2123 (2003).
Porat, R.M. et al. Specific induction of tie1 promoter by disturbed flow in atherosclerosis-prone vascular niches and flow-obstructing pathologies. Circ Res 94, 394–401 (2004).
Arai, F. et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149–161 (2004).
Shewchuk, L.M. et al. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure 8, 1105–1113 (2000).
Barton, W.A. et al. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat Struct Mol Biol 13, 524–532 (2006).
Fiedler, U. et al. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem 278, 1721–1727 (2003).
Barton, W.A., Tzvetkova, D. & Nikolov, D.B. Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition. Structure 13, 825–832 (2005).
Patan, S. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res 56, 1–21 (1998).
Partanen, J. et al. Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development 122, 3013–3021 (1996).
Puri, M.C. & Bernstein, A. Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci USA 100, 12753–12758 (2003).
Vikkula, M. et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181–1190 (1996).
Calvert, J.T. et al. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8, 1279–1289 (1999).
Korpelainen, E.I., Karkkainen, M., Gunji, Y., Vikkula, M. & Alitalo, K. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18, 1–8 (1999).
Morris, P.N. et al. Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J Mol Med 83, 58–63 (2005).
Morris, P.N., Dunmore, B.J. & Brindle, N.P. Mutant Tie2 causing venous malformation signals through Shc. Biochem Biophys Res Commun 346, 335–338 (2006).
Suri, C. et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 282, 468–471 (1998).
Thurston, G. et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511–2514 (1999).
Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6, 460–463 (2000).
Nambu, H. et al. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther 11, 865–873 (2004).
Joussen, A.M. et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 160, 1683–1693 (2002).
Nykanen, A.I. et al. Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107, 1308–1314 (2003).
Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H.P. & Tschope, C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 111, 97–105 (2005).
Zhao, Y.D., Campbell, A.I., Robb, M., Ng, D. & Stewart, D.J. Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ Res 92, 984–991 (2003).
Jung, H., Gurunluoglu, R., Scharpf, J. & Siemionow, M. Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival. Microsurgery 23, 374–380 (2003).
Morisada, T. et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105, 4649–4656 (2005).
Tammela, T. et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105, 4642–4648 (2005).
Shimoda, H. et al. Abnormal recruitment of periendothelial cells to lymphatic capillaries in digestive organs of angiopoietin-2-deficient mice. Cell Tissue Res 328, 329–337 (2007).
Holash, J., Wiegand, S.J. & Yancopoulos, G.D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18, 5356–5362 (1999).
Zagzag, D. et al. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 159, 391–400 (1999).
Ahmad, S.A. et al. The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res 61, 1255–1259 (2001).
Oliner, J. et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 6, 507–516 (2004).
Tait, C.R. & Jones, P.F. Angiopoietins in tumours: the angiogenic switch. J Pathol 204, 1–10 (2004).
Tanaka, S., Wands, J.R. & Arii, S. Induction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis. J Hepatol 44, 233–235 (2006).
Perry, B.N. et al. Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol 126, 2316–2322 (2006).
Lin, P. et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci USA 95, 8829–8834 (1998).
Hangai, M. et al. Systemically expressed soluble Tie2 inhibits intraocular neovascularization. Hum Gene Ther 12, 1311–1321 (2001).
Das, A. et al. Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization. Lab Invest 83, 1637–1645 (2003).
Baffert, F. et al. Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res 94, 984–992 (2004).
Ward, N.L., Van Slyke, P. & Dumont, D.J. Functional inhibition of secreted angiopoietin: a novel role for angiopoietin 1 in coronary vessel patterning. Biochem Biophys Res Commun 323, 937–946 (2004).
Cho, C.H. et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 97, 86–94 (2005).
Thurston, G. et al. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 132, 3317–3326 (2005).
Thistlethwaite, P.A. et al. Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg 122, 65–73 (2001).
Sullivan, C.C. et al. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci USA 100, 12331–12336 (2003).
Peters, K.G. et al. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res 59, 51–71 (2004).
Kontos, C.D. et al. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18, 4131–4140 (1998).
Fujikawa, K. et al. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp Cell Res 253, 663–672 (1999).
Papapetropoulos, A. et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275, 9102–9105 (2000).
Babaei, S. et al. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 162, 1927–1936 (2003).
Harfouche, R. et al. Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. Faseb J 17, 1523–1525 (2003).
Saito, M., Hamasaki, M. & Shibuya, M. Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF. Cancer Sci 94, 782–790 (2003).
DeBusk, L.M., Hallahan, D.E. & Lin, P.C. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res 298, 167–177 (2004).
Jones, N. & Dumont, D.J. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 17, 1097–1108 (1998).
Master, Z. et al. Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak. Embo J 20, 5919–5928 (2001).
Jones, N. et al. A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function. Mol Cell Biol 23, 2658–2668 (2003).
Huang, L., Turck, C.W., Rao, P. & Peters, K.G. GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene 11, 2097–2103 (1995).
Jones, N. et al. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274, 30896–30905 (1999).
Audero, E. et al. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells. J Biol Chem 279, 13224–13233 (2004).
Hughes, D.P., Marron, M.B. & Brindle, N.P. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ Res 92, 630–636 (2003).
Tachibana, K., Jones, N., Dumont, D.J., Puri, M.C. & Bernstein, A. Selective role of a distinct tyrosine residue on Tie2 in heart development and early hematopoiesis. Mol Cell Biol 25, 4693–4702 (2005).
Fachinger, G., Deutsch, U. & Risau, W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18, 5948–5953 (1999).
Carlson, T.R., Feng, Y., Maisonpierre, P.C., Mrksich, M. & Morla, A.O. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 276, 26516–26525 (2001).
Cascone, I., Napione, L., Maniero, F., Serini, G. & Bussolino, F. Stable interaction between {alpha}5{beta}1 integrin and tie2 tyrosine kinase receptor regulates endothelial cell response to ang-1. J Cell Biol 170, 993–1004 (2005).
Dallabrida, S.M., Ismail, N., Oberle, J.R., Himes, B.E. & Rupnick, M.A. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 96, e8–24 (2005).
Weber, C.C. et al. Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization. J Biol Chem 280, 22445–22453 (2005).
McCarthy, M.J. et al. Potential roles of metalloprotease mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1. Lab Invest 79, 889–895 (1999).
Marron, M., Hughes, D.P., Edge, M.D., Forder, C.L. & Brindle, N. Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J Biol Chem 275, 39741–39746 (2000).
Tsiamis, A.C., Morris, P.N., Marron, M.B. & Brindle, N.P. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc Res 63, 149–158 (2002).
Yabkowitz, R. et al. Regulation of tie receptor expression on human endothelial cells by protein kinase C-mediated release of soluble tie. Blood 90, 706–715 (1997).
Voskas, D. et al. A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice. Am J Pathol 166, 843–855 (2005).
Du, L. et al. Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 348, 500–509 (2003).
Yu, Y., Varughese, J., Brown, L.F., Mulliken, J.B. & Bischoff, J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 159, 2271–2280 (2001).
Wang, H., Zhang, Y., Toratani, S. & Okamoto, T. Transformation of vascular endothelial cells by a point mutation in the Tie2 gene from human intramuscular haemangioma. Oncogene 23, 8700–8704 (2004).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Saharinen, P., Eklund, L., Alitalo, K. (2008). Angiopoietins and Tie Receptors. In: Figg, W.D., Folkman, J. (eds) Angiogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71518-6_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-71518-6_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-71517-9
Online ISBN: 978-0-387-71518-6
eBook Packages: MedicineMedicine (R0)